Cardiospheres and cardiosphere-derived cells as therapeutic agents following myocardial infarction (Q38055511)

27 August 2017

Cardiospheres and cardiosphere-derived cells as therapeutic agents following myocardial infarction (English)

1 reference

27 August 2017

myocardial infarction

1 reference

Michelle Kreke

1

1 reference

27 August 2017

Rachel Ruckdeschel Smith

series ordinal

2

1 reference

27 August 2017

Linda Marbán

series ordinal

3

1 reference

27 August 2017

Eduardo Marbán

series ordinal

4

1 reference

27 August 2017

language of work or name

1 reference

1 September 2012

1 reference

Expert Review of Cardiovascular Therapy

27 August 2017

1 reference

27 August 2017

10

1 reference

27 August 2017

9

1 reference

27 August 2017

1185-1194

1 reference

Adult cardiac stem cells are multipotent and support myocardial regeneration

27 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Evidence for cardiomyocyte renewal in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Neural stem cells and neurospheres--re-evaluating the relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Performance of the traditional age, sex, and angina typicality-based approach for estimating pretest probability of angiographically significant coronary artery disease in patients undergoing coronary computed tomographic angiography: results from t

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

The immunomodulatory capacity of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Immune response to stem cells and strategies to induce tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Myocardial regenerative therapy: immunologic basis for the potential "universal donor cells".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Chromosomal variability of human mesenchymal stem cells cultured under hypoxic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Paracrine mechanisms in adult stem cell signaling and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Identification and characterization of a novel multipotent sub-population of Sca-1⁺ cardiac progenitor cells for myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Sca-1+ cardiosphere-derived cells are enriched for Isl1-expressing cardiac precursors and improve cardiac function after myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Characterization and functionality of cardiac progenitor cells in congenital heart patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

21 January 2018

Human cardiac stem cells

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Cardiosphere-derived cells improve function in the infarcted rat heart for at least 16 weeks--an MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Expansion of human cardiac stem cells in physiological oxygen improves cell production efficiency and potency for myocardial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Human cardiac stem cells isolated from atrial appendages stably express c-kit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Repression of cardiac hypertrophy by KLF15: underlying mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Imaging survival and function of transplanted cardiac resident stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial in

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Long-term effects of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: 5-year results from the randomized-controlled BOOST trial--an echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intracoronary infusion of selected autologous bone marrow stem cells improves longitudinal myocardial strain and strain rate in patients with old anterior myocardial infarction without recent revascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intramyocardial, autologous CD34+ cell therapy for refractory angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Results of intracoronary stem cell therapy after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients After Acute Myocardial Infarction and Left Ventricular Dysfunction: Study Rationale and Design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.12.102

21 January 2018

Identifiers

DOI

10.1586/ERC.12.102

1 reference

27 August 2017

1 reference